NPM-ALK transgenic mice spontaneously develop T-cell lymphomas and plasma cell tumors
Open Access
- 1 March 2003
- journal article
- research article
- Published by American Society of Hematology in Blood
- Vol. 101 (5) , 1919-1927
- https://doi.org/10.1182/blood-2002-05-1343
Abstract
Anaplastic Large CellLymphomas (ALCLs) carry translocations in which the anaplastic lymphoma kinase (ALK) gene is juxtaposed to various genes, the most common oKeywords
This publication has 37 references indexed in Scilit:
- In Vivo Interference with Skp1 Function Leads to Genetic Instability and Neoplastic TransformationMolecular and Cellular Biology, 2002
- Anaplastic lymphoma kinase (ALK) activates Stat3 and protects hematopoietic cells from cell deathOncogene, 2002
- Activation of Anaplastic Lymphoma Kinase Receptor Tyrosine Kinase Induces Neuronal Differentiation through the Mitogen-activated Protein Kinase PathwayJournal of Biological Chemistry, 2001
- Transformation and Stat activation by derivatives of FGFR1, FGFR3, and FGFR4Oncogene, 2000
- Nucleolar protein B23 has molecular chaperone activitiesProtein Science, 1999
- The t(2;5) in Human LymphomasLeukemia & Lymphoma, 1998
- A lineage-specific transcriptional silencer regulates CD4 gene expression during T lymphocyte developmentCell, 1994
- Fusion of a Kinase Gene, ALK , to a Nucleolar Protein Gene, NPM , in Non-Hodgkin's LymphomaScience, 1994
- Abelson murine leukemia virus transforms preneoplastic Eμ‐myc transgene‐carrying cells of the B‐lymphocyte lineage into plasmablastic tumorsInternational Journal of Cancer, 1990
- Induction of Plasma Cell Tumours in BALB/c Mice with 2,6,10,14-Tetramethylpentadecane (Pristane)Nature, 1969